Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Single Center Study Assessing Tenapanor as a Non-CFTR-mediated Treatment of CF-related Constipation in People With CF.

NCT06810167 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT06810167
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06810167 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Single Center Study Assessing Tenapanor as a Non-CFTR-mediated Treatment of CF-related Constipation in People With CF.
Lead sponsor
Massachusetts General Hospital
Phase
Phase 3
Overall status
Active, not recruiting
Start date
June 1, 2025
Completion date
June 30, 2027
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

constipation, cystic fibrosis